/cdn.vox-cdn.com/uploads/chorus_asset/file/24993390/DSC05737.jpg)
Tag: medicines
Healthcare Roundup: Market Discussions
The latest market discussions covering the healthcare sector. Published exclusively on x Newswires at 4:20 a.m. ET, 12:20 p.m. ET and 4:50 p.m. ET. 09:02
Merck MS drug fails to meet goal in late-stage trials
MerckThe multiple sclerosis drug evobrutinib failed to meet a key goal in late-stage trials. The German pharmaceutical company’s Phase 3 clinical trials of the drug
AbbVie to buy Cancer Biotech ImmunoGen for more than $10 billion
Updated November 30, 2023 at 10:37 a.m. ET Pharmaceutical company AbbVie agreed to buy the biotechnology ImmunoGen for $10.1 billion in a new bet on
Ozempic is the new guest at Thanksgiving this year
This Thanksgiving collides with a national conversation about Ozempic, Wegovy and other blockbuster weight loss and diabetes drugs. People who take these medications say they
The Covid vaccine windfall revolves around Pfizer and Moderna
Two years ago, the United States was in a Covid panic attack during Thanksgiving week. The Omicron variant had emerged as a creature from the
The first drug Crispr has just been approved
In sickle cell disease, abnormal hemoglobin makes blood cells hard and crescent-shaped. These distorted cells clump together and block blood flow to the organs, causing
Healthcare Roundup: Market Discussions
The latest market discussions covering the healthcare sector. Published exclusively on x Newswires at 4:20 a.m. ET, 12:20 p.m. ET and 4:50 p.m. ET. 04:24
Wegovy reduces risk of heart attack and stroke in landmark trial
The current trial was sponsored by Novo Nordisk, the maker of Wegovy and Ozempic, and followed patients for two years around the world. Half of
Wuxi Biologics Unit’s Hong Kong IPO closes order book a day early, sources say
A unit of Chinese contract drugmaker Wuxi Biologics has closed its order book a day early for its IPO and is likely to price the
FDA approves Eli Lilly’s Mounjaro for weight loss in the US as Zepbound
Updated November 8, 2023 at 4:07 p.m. ET US drug regulators have approved the expansion of the use of Elie LillyIt is the diabetes drug
FDA approves Eli Lilly’s Mounjaro for weight loss in the US as Zepbound
Updated November 8, 2023 at 2:22 p.m. ET US drug regulators have approved the expansion of the use of Elie LillyIt is the diabetes drug